Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Prostate Biopsy

Hormonal therapy for prostate cancer

Radiation therapy for prostate cancer

Treatment of prostatitis

Cryosurgery for prostate cancer

Prostate Cancer Epidemiology Worldwide

Diagnosis of Benign Prostatic Hyperplasia (BPH)

Breakthroughs in Prostate Cancer Treatments

What is the PSA Test?

Brachytherapy for Prostate Cancer

Choosing the best treatment of prostate cancer - by stage

See more featured articles »

Prostate Cancer Cell Dormancy and Activation

Precancerous conditions of the prostate

Prostate Cancer Epidemiology

Prostate Cancer and Diet

What is benign prostatic hyperplasia?

Types of PSA Test

What is Prostatitis?

The International Prostate Symptoms Score (IPSS)

Single Nucleotide Polymorphisms and Prostate Cancer

What is the PCA3 Test?

Prostatitis symptoms

Prostate Cancer Risk Factors

Life after prostate cancer treatment

Prostate cancer complications

PSA Test in Men Who Have Been Treated for Prostate Cancer

Prostate Cancer Screening

Prostate cancer alternative and complementary therapies

Should MRI be Used to Diagnose Prostate Cancer?

Prostate Cancer and Exercise

Survival rates of prostate cancer

Prostate Cancer and Genetics

What is the Gleason Score?

Prostate Cancer Questions

Causes of prostatitis

Recent Genetic Breakthroughs in Prostate Cancer Research

Symptoms of Benign Prostatic Hyperplasia (BHP)

Prostate Cancer Research

What Should You Avoid Before a PSA Test?

Prostate Cancer Diagnosis

Vasectomy and prostate cancer: Myth or reality?

Treatment of Benign Prostatic Hyperplasia (BHP)

Differentiating between prostate cancer and prostate enlargement

Gallium Ga 68-labeled PSMA-11 PET/CT Imaging for Prostate Cancer

What is Prostatectomy?

Prostate Cancer Treatment

PSA False Positive and False Negative Results

Palliative treatment and end of life care for prostate cancer

Prostate Cancer Partin Tables

What is medical castration?

Gold Nanoparticles Use in Prostate Cancer

Can Curcumin Prevent or Treat Prostate Cancer?

What is TURP?

Causes of benign prostatic hyperplasia

Rectal Examination for Prostate Cancer

Diagnosis of prostatitis

Prostate Cancer Staging

The Prostate

Prostate cancer prevention

Prostate Cancer Symptoms

Latest Prostate Cancer News and Research

Why are more older people dying after falls?

For a while, walking the dog felt hazardous. Earl Vickers was accustomed to taking Molly, his shepherd-boxer-something-else mix, for strolls on the beach or around his neighborhood in Seaside, California. A few years ago, though, he started to experience problems staying upright.

15 Sep 2025

Primary care providers less likely to recommend PSA testing for Black men

Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or considered during appointments with their primary-care clinicians to discuss a common screening test.

13 Sep 2025

Review highlights immunomodulatory and therapeutic effects of ginseng

Ginseng has long been used in traditional medicine to replenish Qi and address deficiency syndromes, often manifesting as fatigue and immune compromise.

13 Sep 2025

Faster and cheaper MRI proves effective in detecting prostate cancer

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, according to clinical trial results led by UCL, UCLH and the University of Birmingham.

11 Sep 2025

RAB26 identified as a critical regulator of prostate cancer aggressiveness

Prostate cancer (PCa) is one of the most common malignant tumors in men worldwide. While early detection has improved patient outcomes, effective therapies for advanced disease remain limited.

11 Sep 2025

Johns Hopkins team develops urine-based test for prostate cancer detection

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers present in urine, funded in part by the National Institutes of Health.

9 Sep 2025

Frailty and microbial imbalance drive GI complications in bladder cancer surgery

Gastrointestinal (GI) complications, such as postoperative ileus (POI) and intra-abdominal infections (IAI), remain a major concern after radical cystectomy for bladder cancer.

8 Sep 2025

Colorectal cancer identified by its unique microbial fingerprint

Colorectal cancer is unique in having its own microbial 'fingerprint' – according to new research from the University of East Anglia.

3 Sep 2025

Urine test identifies three biomarkers for accurate prostate cancer detection

2 Sep 2025

Prostate cancer rates rise as mortality decline slows in the United States

Today, the American Cancer Society (ACS) released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States.

2 Sep 2025

MicroRNA panels show promise for improving prostate cancer diagnosis

Prostate cancer is highly heterogeneous, ranging from slow-growing tumors to aggressive, life-threatening disease.

2 Sep 2025

Androgen deprivation therapy lowers satisfaction after penile prosthesis surgery

Prostate cancer is the most common malignancy among men, with over 160,000 new cases diagnosed annually in the United States.

1 Sep 2025

Study provides evidence for a causal genetic link between prostate cancer and urothelial carcinoma

Prostate cancer is among the most common cancers in men and a leading cause of cancer-related deaths. With improved detection and therapies, survival rates have risen, but this progress comes with a new concern: the risk of secondary primary malignancies.

1 Sep 2025

Most Americans unaware that early prostate cancer shows no symptoms

A recent survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) focused on Americans' awareness of the signs and symptoms of prostate cancer.

28 Aug 2025

Molecular profiling identifies prostate cancer patients who benefit most from chemotherapy

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit from unpleasant side effects, according to a new study led by UCL researchers.

28 Aug 2025